Curi Capital, LLC

Position in NEO — Neogenomics Inc

CIK 1332905 CHICAGO, IL

Position in NEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$633,096

-$347,052 QoQ

Shares Held

85,323

+2.4% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Curi Capital, LLC holds $113,657,199 across 14 Diagnostics & Research names. NEO ranks #6 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	280,064	$53,100,133
2	IDXX	Idexx Laboratories Inc /De	57,201	$32,140,669
3	TMO	Thermo Fisher Scientific Inc.	46,597	$22,903,822
4	VCYT	Veracyte, Inc.	44,060	$1,419,171
5	ILMN	Illumina, Inc.	6,666	$821,651
6	NEO	Neogenomics Inc This page	85,323	$633,096
7	GRAL	GRAIL, Inc.	9,006	$465,429
8	LH	Labcorp Holdings Inc.	1,644	$438,635

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$633,096	85,323	+2.4%	Shares	Other	2026-05-15
2025-12-31	$980,148	83,346	0.0%	Shares	Other	2026-02-17
2025-09-30	$643,431	83,346	+0.1%	Shares	Other	2025-11-13
2025-06-30	$608,630	83,260	-72.8%	Shares	Other	2025-08-14
2022-03-31	$3,715,530	305,805	+21.8%	Shares	Sole	2022-05-06
2021-12-31	$8,569,033	251,144	+3.1%	Shares	Sole	2022-01-26
2021-09-30	$11,748,321	243,539	+1.6%	Shares	Sole	2021-10-20
2021-06-30	$10,831,856	239,802	+24.7%	Shares	Sole	2021-08-13
2021-03-31	$9,274,870	192,305	+6.5%	Shares	Sole	2021-05-12
2020-12-31	$9,718,120	180,500	+2.3%	Shares	Sole	2021-02-11
2020-09-30	$6,510,900	176,495	-2.8%	Shares	Sole	2020-11-10
2020-06-30	$5,625,131	181,573	+16.7%	Shares	Sole	2020-08-05
2020-03-31	$4,296,612	155,618	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.